ENO2 and coronary artery disorder: Infants with CHD have a preoperative increase in neuron-specific marker phosphorylated neurofilament heavy and the calcium-binding protein S100B, and detectable levels of neuron-specific enolase (NSE) in their plasma, which suggest a compromised blood–brain barrier.